133 related articles for article (PubMed ID: 35753280)
1. Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.
Montgomery MP; Zhong Y; Roberts E; Asher A; Bixler D; Doshani M; Christensen A; Eckert M; Weng MK; Carry M; Samuel CR; Teshale EH
Drug Alcohol Depend; 2022 Aug; 237():109540. PubMed ID: 35753280
[TBL] [Abstract][Full Text] [Related]
2. Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews.
Carry M; Bixler D; Weng MK; Doshani M; Roberts E; Montgomery MP
Harm Reduct J; 2022 Sep; 19(1):100. PubMed ID: 36050735
[TBL] [Abstract][Full Text] [Related]
3. Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.
Des Jarlais DC; Behrends CN; Corcorran MA; Glick SN; Perlman DC; Kapadia SN; Lu X; Feelemyer J; LaKosky P; Prohaska SM; Schackman BR
Public Health Rep; 2022; 137(6):1066-1069. PubMed ID: 36113105
[TBL] [Abstract][Full Text] [Related]
4. Were Needles Everywhere?: Differing Views on Syringe Waste and Disposal Associated With Needs-Based Syringe Services Programs Among Community Partners and Persons Who Inject Drugs.
Hershow RB; Love Pieczykolan L; Worthington N; Adams M; McDonald R; Wilson S; McBee S; Balleydier S; Curran KG
Subst Use Misuse; 2024; 59(8):1174-1181. PubMed ID: 38509704
[TBL] [Abstract][Full Text] [Related]
5. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
6. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
Corcorran MA; Austin EJ; Behrends CN; Briggs ES; Frost MC; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
J Addict Med; 2023 Jan-Feb 01; 17(1):e36-e41. PubMed ID: 35916422
[TBL] [Abstract][Full Text] [Related]
7. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
8. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
9. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
[TBL] [Abstract][Full Text] [Related]
10. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
[TBL] [Abstract][Full Text] [Related]
11. State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.
Fernández-Viña MH; Prood NE; Herpolsheimer A; Waimberg J; Burris S
Public Health Rep; 2020; 135(1_suppl):128S-137S. PubMed ID: 32735195
[TBL] [Abstract][Full Text] [Related]
12. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
[TBL] [Abstract][Full Text] [Related]
13. A wound care and immunization needs assessment for participants of a mobile syringe services program in Austin, TX.
Britton TR; Clague MR; Zagorski CM; Hill LG; Loera LJ
J Am Pharm Assoc (2003); 2023; 63(1):361-365.e1. PubMed ID: 36549930
[TBL] [Abstract][Full Text] [Related]
14. Police officer attitudes towards syringe services programming.
Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
16. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
[TBL] [Abstract][Full Text] [Related]
17. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
[TBL] [Abstract][Full Text] [Related]
18. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
[TBL] [Abstract][Full Text] [Related]
19. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
[TBL] [Abstract][Full Text] [Related]
20. Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.
Hayes BT; Favaro J; Coello D; Behrends CN; Jakubowski A; Fox AD
Int J Drug Policy; 2022 Jan; 99():103474. PubMed ID: 34619446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
